Ignite Creation Date:
2024-05-06 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 2:16 PM
Study NCT ID:
NCT05097274
Status:
RECRUITING
Last Update Posted:
2024-04-25
First Post:
2021-10-15
Brief Title:
The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation
Sponsor:
Institute of Cancer Research United Kingdom
Organization:
Institute of Cancer Research United Kingdom
Study Overview
Official Title:
An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation GENPET
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GENPET
Brief Summary:
The aim of the study is to determine if PET-CT imaging using contrast recommended in clinical guidelines is superior to combined bone scan and MRICT of the abdomen pelvis in detecting the increased incidence of metastasis nodaldistant outside the pelvis in men with prostatic carcinoma with mutations in any of the following germline DNA repair genes BRCA1 BRCA2 MSH2 MSH6 MLH1 PMS2 CHEK2 PALB2 ATM
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None